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Bronchiolitis Obliterans 
Talmadge E. King, Jr. 
National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado, USA 
Abstract. Bronchiolitis obliterans in the adult patient is a relatively uncom- 
mon and vexing clinical entity. This confusion results because this patho- 
logic finding occurs in a variety of diverse clinical settings. Bronchiolitis 
obliterans is a fibrotic process that primarily affects the small conducting 
airways. The lesion results from damage to the bronchiolar epithelium and 
the repair process leads to excessive proliferation of granulation tissue. The 
alveoli adjacent o the small airway are almost always involved; however, a
considerable portion of the interstitium is usually spared. The findings in 
these patients may physiologically and radiographically mimic chronic ob- 
structive pulmonary disease (COPD). On the other hand, some of the pro- 
cesses associated with bronchiolitis obliterans result in restrictive or mixed 
restrictive and obstructive ventilatory defects; consequently, they may be 
confused with other diffuse infiltrative lung disorders. This review will focus 
principally on bronchiolitis obliterans in adults, which, until recently, was 
considered rare. There has been heightened interest in this process in adults 
because of its association with the connective tissue diseases, its develop- 
ment following toxic fume exposure, its occurrence as a result of chronic 
graft versus host reactions, and the increasing recognition of patients with 
idiopathic forms of the disease that have an insidious onset often confused 
with more common problems uch as COPD or idiopathic pulmonary fibro- 
sis. 
Key words: Bronchiolitis obliterans--Inhalation, toxic fumes--Bronchiol- 
i t ismPneumonia, organizing--Connective tissue disease. 
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Introduction 
Bronchiolitis in the adult patient is a relatively uncommon and vexing clinical 
entity [67]. This confusion results because this pathologic finding occurs in a 
variety of diverse clinical settings. Furthermore, inflammatory processes in- 
volving the "small airways" may initially go "unnoticed" in the adult because 
the resistance of the peripheral airways falls considerably after approximately 
age 5 and thus leaves the small airways of the adult relatively silent, physiologi- 
cally and symptomatically [57]. As the disease progresses and becomes clini- 
cally evident, many of the findings in these patients may physiologically and 
radiographically mimic chronic obstructive pulmonary disease. On the other 
hand, some of the processes associated with bronchiolitis result in restrictive or 
mixed restrictive/obstructive ventilatory defects and may be confused with 
other diffuse infiltrative lung disorders. In addition, different terms have been 
applied to these diseases, based mainly on the pathologic descriptions: bronchi- 
olitis obliterans, bronchiolitis, bronchiolitis obliterans with organizing pneumo- 
nia, bronchiolitis fibrosa obliterans, bronchiolitis and diffuse interstitial pneu- 
monia, follicular bronchitis/bronchiolitis, and small airway disease. 
This review will focus principally on bronchiolitis obliterans in adults, 
which, until recently, was considered rare (Table I). There has been heightened 
interest in this process in adults because of its association with the connective 
tissue diseases, its development following toxic fume exposure, itsoccurrence 
as a result of chronic graft versus host reactions, and the increasing recognition 
of patients with idiopathic forms of the disease. 
Bronchiolitis obliterans of known etiology 
Bronchiolitis obliterans is a fibrotic lung disease that primarily affects the small 
conducting airways, often sparing a considerable portion of the interstitium. 
The lesion results from damage to the bronchiolar epithelium and the repair 
process leads to excessive proliferation of granulation tissue. The alveoli adja- 
cent to the small airways are almost always involved [33]. Until recently there 
have been only case reports describing this lesion in various clinical settings. 
Consequently, any uncertainties regarding the epidemiology, pathophysiology, 
long-term sequelae, and therapy of bronchiolitis obliterans exist. 
Toxic Fume Inhalation 
Toxic fume exposure, especially to "nitrous fume," may cause acute respira- 
tory failure as a result of pulmonary edema and the development of the adult 
respiratory distress syndrome (ARDS), leading in some cases to death (either 
acutely or after a 4-6 h latent period). It is now recognized that toxic fume 
exposures are a significant industrial and environmental hazard occurring in a 
number of settings, for example, among agricultural workers (silo filler's dis- 
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Table 1. Clinical classification of bronchiolitis oblit- 
erans 
Bronchiolitis obliterans of known etiology 
Toxic fume inhalation 
Postinfectious bronchiolitis obliterans 
Diffuse lesions 
Localized lesions 
Mineral dust exposure 
Bronchiolitis obliterans of unknown etiology 
Bronchiolitis obliterans and organizing pneumonia 
Associated with connective tissue disease 
De novo process 
Drug reaction 
Associated with organ transplantation 
Associated with other diseases 
Idiopathic pulmonary fibrosis 
Hypersentivity pneumonitis 
Malignant histiocytosis 
Chronic eosinophilic pneumonia 
Panbronchiolitis 
Respiratory bronchiolitis 
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ease), chemical workers, munition and missile industries, gold and coal mining, 
and arc welding in confined spaces [60, 98] (Table 2). 
Three clinical patterns may follow exposure to these toxic gases in those 
who survive the initial insult [59, 85, 97, 99, 126]. First after mild exposure 
individuals may develop any 1 of several findings: cough, dyspnea, fatigue, 
cyanosis, vomiting, hemoptysis, arterial hypoxemia, vertigo, somnolence, 
headache, emotional difficulties, and loss of consciousness. These usually re- 
solve in hours but may persist for several weeks before complete recovery. 
Second, at higher concentrations of exposure, pulmonary edema frequently 
occurs. These patients may have mild or no symptoms at the time of exposure, 
only to develop a clinical picture of severe ARDS several hours later (3-30 h). 
Recovery is usual but death may occur at this stage. Finally, after recovery or 
in patients who had no initial illness following exposure, there may be a recur- 
rence or onset of illness a few weeks later (2-6 weeks). This phase is character- 
ized by the onset of a nonproductive cough, dyspnea, and an irreversible ob- 
structive ventilatory defect (i.e. bronchiolitis obliterans) [25, 35, 85]. 
The roentgenographic pattern of bronchiolitis obliterans is variable. Most 
commonly a miliary or discretely nodular pattern occurs and is considered 
characteristic of this type of bronchiolitis obliterans [25, 59, 85, 91] (Fig. 1). 
Occasionally, only pulmonary hyperinflation is seen on chest x-ray. Rarely, the 
chest film may be normal [87, I33]. Histologically, the picture is of a pure 
bronchiolitis obliterans without organizing pneumonia or alveolar wall inflam- 
mation. The extent of the airway damage and functional impairment is related 
to the type and amount of fume inhalation. 
Treatment of the late fibrotic stage of bronchiolitis obliterans may not be 
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Table 2. Setting of exposure to toxic gases, fumes, and mists associated with bronchiolitis 
obliterans 
Nitrogen dioxide ("nitrous fumes") 
Spillage of nitric acid. component of jet and missile fuel; metal pickling: silo gas; chemical 
manufacturing: explosive, dyes, lacquers, celluloid; detonation of explosives; electric arc or 
acetylene gas welding; contamination of nesthetic gases (nitrous oxide gas cylinder); nitro- 
cellulose combustion; tobacco smoke; astronauts, firemen, or oth rs exposed to burning 
materials 
Sulfur dioxide 
Burning of sulfur-containing fossil fuels; bleaching of wool, straw, and wood pulp; sugar 
refining and fruit preserving; fungicide; refrigerant; ore smelting; acid production 
Ammonia 
Fertilizer, refrigerator, explosives production 
Chlorine 
Bleaching, disinfectant, plastic making 
Phosgene 
Chemical industry, dye andinsecticide making 
Chloropicrin 
Trichloroethylene 
Ozone 
Arc welding, air, sewage, and water treatment 
Cadmium oxide 
Ore: smelting, alloying, welding 
Methyl sulfate 
Hydrogen sulfide 
Natural gas making, paper pulp, sewage treatment, tannery work 
Hydrogen fluoride 
Etching, petroleum industry, silk-working 
Talcum powder 
Hydrous magnesium silicate 
Oxygen toxicity 
Free-base cocaine 
helpful. Therefore, early recognition and treatment of these patients are impor- 
tant. Persons exposed acutely should be observed in the hospital for 48 hs, 
followed by weekly or biweekly evaluations for 6-8 weeks. Treatment with 
corticosteroids has been demonstrated to be useful in the management of both 
the acute phase (i.e., pulmonary edema) and the late phase illness (i.e., bron- 
chiolitis obliterans) [59, 64, 85,121]. Once instituted, therapy should be contin- 
ued for a minimum of 8 weeks, since relapses have been reported with the 
premature cessation of therapy [64, 121]. Treatment may be required for sev- 
eral months to years. Bronchodilators are occassionally helpful and probably 
should be given a trial in all symptomatic patients. 
In general, the prognosis for survivors (one-third ie acutely) of toxic fume 
inhalation is quite good [101]. Those who subsequently develop bronchiolitis 
obliterans may be permanently disabled and experience progressive disease 
and death over several months. 
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Fig. 1. Bronchiolitis obliterans. 
A Initial posteroanterior 
roentgenogram of the chest 
shows diffuse parenchymal 
infiltration of a discretely 
nodular or miliary pattern. B 
Close-up view of the right lower 
lobe region demonstrates this 
nodularity. 
Postinfectious Bronchiolitis Obliterans 
Bronchiolitis obliterans is the second most common lower respiratory tract 
illness requiring hospitalization of  infants and young children [I13, 131]. It 
occurs primarily as a result of a viral infection, usually the respiratory syncytial 
virus (Table 3). Infectious bronchiolitis obliterans is rarely seen in children 
older than age 2 or in adults. When it occurs in older children and young adults, 
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Table 3. Infectious causes of bronchiolitis obliterans 
Viral 
Respiratory syncytial virus; adenovirus (types 7, 3, 21, 1, 2, 5, 
6); rhinovirus; parainfluenza; influenza; measles; mumps; vari- 
celia zoster; cytomegalovirus 
Other infectious agents 
Mycoplasma pneumoniae; Legionella pneumophilia; Serratia 
marcescens 
T. E. King, Jr. 
it has been associated primarily with Mycoplasma pneumoniae, but a number 
of other viral and bacterial agents have also been identified [23, 30, 43, 106]. 
The disease may also occur as a nonspecific localized process adjacent o a 
fungal or mycobacterial granuloma [65]. 
The children usually present with an acute illness that begins with mild 
coryza with sneezing. Several days later, cough, dyspnea, tachypnea, tachy- 
cardia, fever, chest wall retraction, sibilant and sonorous rales, expiratory 
wheezing, and, in the worst cases, cyanosis may develop. Prostration and 
respiratory failure are unusual. Recovery is usual and occurs in days or weeks 
[47, 113, 131]. The clinical presentation i adults has not been well character- 
ized since no systematic study of infectious bronchiolitis obliterans in this 
group has been reported. Most patients have a history of an upper respiratory 
tract illness that precedes the onset of dyspnea with exertion, cough, tachy- 
pnea, fever, and wheezing [30, 53, 93]. A number of adults have developed an 
acute or subacute diffuse ventilatory obstruction that has occasionally been 
fatal. 
The radiographic pattern of childhood bronchiolitis is variable. It may be 
normal or show hyperinflation with increased bronchial markings. Subsegmen- 
tal consolidation and collapse may be seen [129]. A pattern similar to diffuse 
interstitial pneumonia often in association with hyperinflation is seen. Some 
patients demonstrate a diffuse nodular or reticulonodular pattern while others 
may have patchy alveolar or ground-glass opacities [10, 44]. Those with nodu- 
lar pattern frequently have "pure" bronchiolitis obliterans on lung biopsy, 
whereas those with the reticulonodular pattern are likely to have more intersti- 
tial inflammation and scarring [10, 44, 131]. It is interesting that 1 of the long- 
term complications of this condition is the development of the Swyer-James- 
MacLeod syndrome, (i.e., unilateral hyperlucent lung) [24, 69]. 
Tests of lung function are usually normal, although increases in both end- 
expiratory lung volume and lung resistance have been reported. Dynamic com- 
pliance and arterial hypoxemia have been demonstrated [47, 130, 131]. It has 
been demonstrated that viral bronchitis may cause abnormalities in lung func- 
tion that include "small airways dysfunction," reduced iffusing capacity, and 
frequency dependence of compliance [23]. Whether or not bronchiolitis in in- 
fancy predisposes to asthma or COPD in later life remains unprove but data 
suggesting such an association have appeared in the literature [47, 52, 78, 79, 
128]. 
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The pathologic features of acute viral bronchiolitis have been previously 
summarized [44, 82, 83, ]33]. The earliest change is necrosis of the respiratory 
epithelium followed by proliferation. Dense plugs of alveolar debris and strands 
of fibrin are seen within small bronchi and bronchioles causing partial or com- 
plete obstruction. A lymphocytic infiltrate with germinal centers may be seen in 
the airway wall. Occasionally, severe and widespread estruction of the respi- 
ratory epithelium may cause denudation and a pronounced inflammatory re- 
sponse that may involve the adjacent peribronchial space and alveolar walls. 
The pathogenetic mechanisms involved in the development of obliterative 
bronchiolitis secondary to infections and the reason for the predilection in 
infants are unknown [84, 131].. 
Treatment is symptomatic, with oxygen therapy and adequate hydration 
being most important [31, 40, 84, 131]. Bronchodilators, antibiotics, and corti- 
costeroids have no proven role in management. Mechanical ventilation is rarely 
required but may be necessary if progressive respiratory failure ensues. 
Occasionally, localized areas of bronchiolitis obliterans are found at open 
lung biopsy performed to rule out carcinoma. These lesions present radiograph- 
ically as an irregular nodule or irregular sublobar area of air-space consolida- 
tion. Surgical resection usually completely resolves this problem. The true 
origin of these lesions is unknown but it is very likely secondary to a resolving 
pneumonia. 
Bronchiolitis Obliterans of Unknown Etiology 
Bronchiolitis Obliterans and Organizing Pneumonia 
The group of patients who are classified as having idiopathic bronchiolitis 
obliterans and organizing pneumonia (BOOP) may represent a subset of pa- 
tients with unrecognized viral syndromes or toxic fume exposures [28, 34, 49, 
66, 123]. The disease onset is usually in the fifth and sixth decade and affects 
men and women equally. A persistent and usually nonproductive cough (84% 
of patients) is the most common presenting symptom. Frequently, patients 
experience dyspnea with exertion (65% of patients) and two-thirds describe 
their onset as a flulike illness with fever, malaise, fatigue, and cough. Almost 
three-fourths of the patients have their symptoms for less than 2 months and 
less than one-fifth of the patients have symptoms for greater than 1 year. 
Cigarette smoking is not a precipitating factor. In three-fourths of the patients 
physical examination reveals crackles (Velcro rales). Wheezing has been found 
in 31% and is usually present with vales. Clubbing is not found and occasionally 
a normal physical examination is present. 
Lung functional abnormalities are variable and there is relatively little cor- 
relation between histopathologic findings and function. Arterial hypoxemia is a 
universal finding in symptomatic patients. When the effect of smoking is con- 
sidered, a higher percentage of patients have a restrictive ventilatory defect. 
Nineteen percent of patients have normal pulmonary function. Relatively few 
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studies of exercise gas exchange have been carried out since most of the studies 
have been retrospective r views of pathologically defined cases. The diffusing 
capacity for carbon monoxide is abnormal in 72% of patients. 
The radiographic manifestations are also variable, but a characteristic pat- 
tern of bilateral, patchy, ground-glass, or alveolar opacities is seen in 72% of 
these cases (Fig. 2). A miliary pattern often confused with miliary tuberculosis 
has been reported in one-fourth of the patients. It has been proposed that the 
combination of radiographic and/or physiological evidence of hyperinflation 
and rales on physical examination is suggestive or bronchiolitis obliterans. This 
may be true of toxic fume exposure or viral-induced bronchiolitis obliterans, 
but it should be pointed out that radiographic evidence of hyperinflation is 
distinctly uncommon i  BOOP. Very rarely (1%) is the x-ray appearance nor- 
mal in patients with BOOP. In Epler and co-workers' [34] recent series, it was 
shown that the s verity of the radiographic abnormalities was significantly 
correlated with the extent of histologic involvement of the respiratory bronchi- 
oles and alveolar ducts but not of the larger terminal bronchioles. 
In BOOP the extent of involvement of the small airways is variable. The 
fibrotic process is patchy and usually involves the airspaces with a peribron- 
chiolar distribution. In 1 series [34] 50% of the cases showed extensive involve- 
ment of the terminal and respiratory bronchioles and two-thirds had significant 
involvement of the alveolar ducts. The cellular infiltrate found in the bronchio- 
lar walls is composed primarily of mononuclear cells, plasma cells, and histio- 
cytes. Occasionally neutrophils are seen in the lumens of these airways. In 
some instances an acute inflammatory exudate is seen in neighboring alveoli. 
The fibrotic processes in these cases are interesting: the early lesions are char- 
acterized by organization of the inflammatory and fibrinous exudates with pro- 
liferating fibroblasts and little collagen deposition. As the lesions progress, 
well-formed plugs of edematous granulation tissue that involve terminal and 
respiratory bronchioles appear and are associated with an intense reaction that 
extends into the alveolar ducts (Fig. 3). Honeycombing is rarely, if ever, seen 
[34, 66]. "Cholesterol," "obstructive," or "endogenous lipid" pneumonia is
occasionally seen but sometimes can be so marked as to cause confusion in the 
diagnosis of this process with pneumonias due to exogenous lipid. It is impor- 
tant that the histologic lesions of BOOP appear uniform in appearance. This 
contrasts with the usual interstitial pneumonia, in which there are areas of 
varying degrees of interstitial fribrosis with foci of honeycombing and mononu- 
clear cell infiltration throughout the involved lung [34, 66]. Tables 4 and 5 
outline the contrasting clinical and pathologic features of bronchiolitis obli- 
terans and usual interstitial pneumonia,  process with which it is frequently 
confused [14, 66]. 
Corticosteroid therapy is effective and clinical improvement is very com- 
mon, often occurring within days of initiation of therapy. As many as two- 
thirds of the patients demonstrate complete clinical and physiological recovery 
following corticosteroid therapy. Death from progressive disease occurs, but is 
infrequent [60]. Early cessation of corticosteroid therapy may be associated 
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Fig. 2, Bronchiolitis obliterans and organizing pneumonia. Appearance in a 38-year-old patient 
with 2-week history of progressive dyspnea with exertion and nonproductive cough. A Initial 
posteroanterior r entgenogram shows mixed alveolar and interstitial infiltrates throughout all lung 
zones but most prominently in both upper lung zones. B Follow-up posteroanterior r entgenogram, 
after corticosteroid therapy, documents marked improvement. 
78 T .E .  King, Jr. 
Fig. 3. Broncbiolitis obliterans and organizing pneumonia. Polypoid masses of granulation tissue 
fill the lumens of respiratory bronchioles and alveolar ducts ttop and right). Adjacent alveolar 
interstices are broadened by a lymphoplasmacytic inflammatory infiltrate, and prominent type II 
pneumocyte hyperplasia is present (H & E, x 50). 
with a recurrence of both symptoms and/or radiographic and physiological 
abnormalities [27, 28, 34]. 
Connective Tissue Diseases 
Rheumatoid Arthritis. Pleuropulmonary manifestations are frequently encoun- 
tered in patients with rheumatoid arthritis (RA): (1) pleural esions with and 
without pleurisy; (2) interstitial lung disease; (3) parenchymal rheumatoid nod- 
ules; (4) Caplan's syndrome; (5) arteritis; and (6) gold-induced interstitial lung 
disease. An increased prevalence of obstructive pulmonary disease has been 
noted [4, 20, 26, 39, 95, 108]. Several studies have demonstrated that factors 
other than tobacco smoking are involved [20, 42, 125, 127] and bronchiolitis 
obliterans has recently been recognized as a cause of the airway obstruction in 
many of these patients [4, 20, 21, 32, 41, 8, 56, 61, 62, 70, 77, 88, 137]. 
The clinical manifestations of bronchiolitis obliterans associated with RA 
help to differentiate it from other pulmonary processes associated with RA. 
There is an abrupt onset of dyspnea nd dry cough often associated with 
inspiratory rales and a midinspiratory squeak. The majority of patients are 
middle-aged women with seropositive RA, often associated with Sjogren's yn- 
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Table 4. Clinical features of bronchiolitis obliterans with organizing pneumo- 
nia (BOOP) and idiopathic pulmonary fibrosis 
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BOOP Idiopathic 
pulmonary 
fibrosis 
Duration of symptoms (range) 3 months 2 yr (2 
(several days- months-5 yr) 
6 months) 
Symptoms (%) 
Cough 67 67 
Fever 58 13 
Dyspnea 50 100 
Upper respiratory infection 21 0 
Associated connective tissue disease 29 19 
Associated occupation exposure 0 31 
Pulmonary function tests (%) 
Restriction 40 85 
Obstruction 20 21 
Decreased iffusing capacity of CO 50 100 
Radiographic manifestations (%) 
Airspace opacities 50 0 
Lobar 46 0 
Bibasilar 4 0 
Interstitial opacities 42 94 
Reticular 42 63 
Reticulonodular 0 13 
Honeycomb 0 19 
Mixed alveolar and interstitial 
opacities 8 6 
Lung volume 
Decreased 25 75 
Normal 75 25 
Adopted from refs 14 and 66 
Table 5. Contrasting pathologic features of bronchiolitis obliterans with organizing pneumonia and 
idiopathic pulmonary fibrosis 
BOOP Idiopathic pulmonary 
fibrosis 
Distribution of lesions 
Location of lesions 
Temporal appearance of changes 
Type of fibrosis 
Honeycomb 
Foamy macrophages 
Patchy, peribronchiolar 
Predominantly airspace 
Uniform, recent 
Fribroblastic 
Unusual 
Common 
Diffuse, random 
Predominantly interstitial 
Varying ages 
Mainly mature (collagen) 
Common 
Unusual 
After ref 66 
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drome [9, 76, I07]. The chest radiography is usually normal. Physiological 
studies usually reveal airflow obstruction, mild to moderate arterial hypoxemia 
and respiratory alkalosis, and normal pulmonary compliance. The rapid rate of 
progression of the airflow obstruction is atypical of COPD. 
Pathologically, there is a lymphoplasmocytic infiltration of small airway 
wails. The lumens are gradually obliterated and bronchiolar wall is destroyed 
by granulation tissue. The lesions are usually confined to the small bronchi and 
bronchioles but occasionally there is patchy organizing pneumonia with granu- 
lation tissue plugs extending into the alveolar ducts. Parenchymal involvement 
is generally localized to the area surrounding the bronchiolitis. The lesions may
be at different stage of development or appear quite uniform [4, 137]. Immuno- 
fluorescence studies show granular IgM or linear IgG depositions along the 
alveolar septa, suggesting a possible direct immune-mediated lung injury [56, 
62]. 
The prognosis for these patients is poor, with a number of early deaths [41]. 
Treatment with antibiotics and bronchodilators has been ineffective. Cortico- 
steroid therapy with or without cyclophosphamide appears to be effective in 
some patients [139]. 
Penicillamine-Associated Bronchiolitis Obliterans in RA. Penicillamine ther- 
apy has been implicated in the pathogenesis of 4 diffuse lung processes: (I) 
bronchiolitis obliterans; (2) interstitial infiltrates, (3) Goodpasture's syndrome, 
and (4)bronchopasm [4, 13, 15, 16, 32, 62, 88, 96, 115, 116, 122, 132, 139]. The 
overwhelming majority of the patients with presumed penicillamine-associated 
bronchiolitis obliterans are women who never smoked. There is a sense that 
this form of bronchiolitis obliterans is characterized by a rapidly deteriorating 
course characterized by pulmonary insufficiency [139]. Breathlessness and 
cough begin within 3-14 months after initiation of penicillamine therapy. In 
one-third of the cases in which the outcome is known, death from progressive 
respiratory failure occurs. Radiographic abnormalities are unusual except for 
mild hyperinflation. Pulmonary function abnormalities are characteristically 
those of airflow obstruction. The histologic appearance is thought by some to 
be distinct from that of other causes of bronchiolitis obliterans because the 
penicillamine-associated cases usually show a concentric, constrictive form of 
bronchiolar obstruction [32, 41, 62, 88, 96, 139]. Although conclusive proof of 
association between bronchiolitis obliterans and penicillamine therapy is lack- 
ing, when confronted with a dyspneic patient with RA being treated with peni- 
cillamine, one should stop use of the drug, consider open lung biopsy, and then 
administer corticosteroids to prevent disease progression [32, 117]. 
Other Connective Tissue Diseases 
Obstructive airway disease has been reported in patients with Sjogren's syn- 
drome [90]. In fact, a number of these patients had bronchiolitis obliterans and 
RA [4]. Pathologic studies are limited but in 2 instances lung biopsy revealed 
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mononuclear cell infiltration around narrowed small airways. A restrictive ven- 
tilatory defect is frequently found in Sjogren's syndrome. This defect probably 
results from the underlying interstitial lung disease associated with the particu- 
lar connective tissue disease and is not due to the sicca complex. 
Less than 5% of patients with systemic lupus erythematous (SLE) have 
airflow obstruction. Kinney and Angelillo [68] have recently reported a patient 
with SLE who developed rapidly progressive airway obstruction and had early 
obliterative bronchiolitis on open lung biopsy. This suggested that this lesion 
may account for the obstructive dysfunction occasionally seen in SLE. 
Small airways disease is not frequently found in nonsmokers with sclero- 
derma even in the presence of interstitial pulmonary involvement [6, 50]. A 
single case of rapidly fatal bronchiolitis obliterans has been reported in a 57- 
year-old woman with circulating antinuclear and rheumatoid factors without 
evidence of a defined connective tissue disease [61]. These authors suggested 
that the serologic abnormalities could be secondary to the inflammation of the 
bronchioles. No data exist to support his hypothesis. 
Schwarz et al. [109] were among the first specifically to distinguish bronchi- 
olitis obliterans as a de novo process in patients with polymyositis and 
dermatomyositis. They also suggested that this lesion was corticosteroid re- 
sponsive. 
Small airways disease has been detected in a relatively high percentage of 
patients with essential mixed cryoglobulinemia, especially if signs of exposure 
to hepatitis B virus are present [8]. Most of these patients had overall normal 
lung function, that is, no evidence of airway obstruction or restriction. On the 
other hand, frequent, although moderate, pulmonary interstitial involvement 
was present on the chest film in most of these otherwise asymptomatic patients. 
Recently, afollicular bronchitis/bronchiolitis has been described in patients 
with rheumatoid arthritis, Sjogren's syndrome, juvenile rheumatoid arthritis, 
immunodeficiency s ndromes, familial lung disorders, chronic infection, and a 
heterogeneous group of patients with a hypersensitivity-type reaction [2, 36, 
37, 112, 138]. Pathologically, there is a follicular bronchitis/bronchiolitis with 
abundant germinal centers in the peribronchiolar regions, characterized by 
hyperplastic follicles located between bronchioles and pulmonary arteries and 
often compressing the bronchiolar lumen into a slitlike or fish-mouth shape. In 
almost all cases, a concentric inflammatory infiltrate of lymphocytes and 
plasma cells surrounded the bronchiole. Patients with rheumatoid arthritis usu- 
ally presented with dyspnea (100%); fever and cough occasionally occurred. 
All have positive rheumatoid factor, often at high levels (1 : 640-1 : 2560). The 
chest film was consistently abnormal with bilateral reticulonodular shadows. 
Pulmonary function tests revealed arterial hypoxemia nd hypocapnia, with a 
widened alveolar-arterial pOz difference. Both obstructive and restrictive pat- 
terns were identified by spirometry, but the restrictive pattern was more com- 
mon. It has been suggested that this lesion may be the precursor of an intersti- 
tial lymphoid pneumonia or pseudolymphoma. It appears to be distinct from 
bronchiolitis obliterans, since the lesions of follicular bronchiolitis obstruct by 
external compression of the bronchioles rather than the direct luminal occlu- 
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sion characteristic of bronchiolitis obliterans. Treatment with corticosteroids 
has yielded variable results. 
Organ Transplantion 
Bone Marrow Transplantation. Acute or chronic graft versus host disease 
(GVHD) frequently complicates the course of patients undergoing allogeneic 
bone marrow transplantation [3, 120]. The acute disease involves the skin, 
liver, and gut. Ninety percent of patients with this complication survive. The 
syndrome of chronic GVHD occurs in 33% of long-term survivors of allogeneic 
transplantation. The protean manifestations of this disorder include scleroder- 
malike skin lesions, sicca syndrome, oral and esophageal mucositis, malab- 
sorption, chronic liver disease, generalized wasting, infections, and disorders 
of immune regulation [3, 26, 111, 118, 120]. Pulmonary disease is uncommon 
and is usually the result of an infectious pneumonia (bacterial, fungal, or viral) 
or idiopathic interstitial pneumonitis. In addition, there are reports of lympho- 
cytic bronchitis and lymphoplasmacytic infiltrate of the trachea nd large bron- 
chi [5]. 
Recently, several cases of rapidly progressive airflow obstruction due to 
bronchiolitis obliterans complicating bone marrow transplantation have been 
found [5t, 63, 73-75, 94, 98, 102-105, 114, 134, 135]. These cases have ap- 
peared in the setting of chronic GVHD and this entity has been postulated to 
play a role in the development of this lung disease. It has been estimated that 
approximately 10% of long-term survivors with chronic GVHD develop the 
complication of severe obstructive pulmonary disease [98]. 
Patients usually present with symptoms of dry, nonproductive cough, 
dyspnea with exertion, bibasilar tales, and scattered wheezing. Hypoxemia is 
common. The chest roentgenogram ay show diffuse interstitial infiltrates, but 
most often in those cases with obstructive lung function the lung fields are 
normal or hyperinflated. It is important to note that abnormal pulmonary func- 
tion has been found in a high percentage of patients following bone marrow 
transplantation, especially in the presence of GVHD. There can be restrictive 
and/or obstructive ventilatory dysfunction associated with impairment in gas 
exchange. Bronchial hyperreactivity was also identified in some patients after 
undergoing transplantation. 
An open lung biopsy is usually necessary to diagnose these cases. Since 
infections are frequent, they should be diagnosed and treated promptly. Bron- 
choalveolar lavage has not been a useful procedure in these cases [22, 71, 103]. 
The pathogenesis of the obstructive ventilatory defect is unknown. Several 
mechanisms have been postulated. Shulman et al. [111] described ectasia nd a 
lymphoplasmocytic infiltration of the tracheal submucosal glands and ducts 
resembling those described in Sjogren's yndrome. In addition, a.dense peri- 
bronchial lymphoplasmocytic infiltrate was occasionally seen. Other investiga- 
tors [5] have found a lymphocytic bronchitis, characterized by lymphocyte- 
associated necrosis of the bronchial mucosa nd submucosal glands. This was 
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often associated with an increased incidence of bronchopneumonia and acute 
bronchitis with mucous plugging. Bronchiolitis obliterans was not noted in this 
study. Lymphocytic bronchitis is thought o represent a pulmonary manifesta- 
tion of GVHD. However, others have questioned its association with acute 
GVHD [51, 75]. Most patients with rapidly progressive airflow obstruction in 
whom lung biopsy has been obtained revealed marked lymphocytic or plasma 
cell and neutrophilic infiltration of the walls of the terminal respiratory bronchi- 
oles and obliteration of the bronchiolar lumina with fibrous tissue and surround- 
ing interstitial fibrosis, that is, "pure" bronchiolitis obliterans [94, 98, 102, 105, 
•34]. Since chronic GVHD is associated with a fibrosing process in other or- 
gans, it is not surprising that bronchiolar fibrosis may be an additional manifes- 
tation of the chronic GVHD. Chronic GVHD is associated with esophageal nd 
sinus disease that may result in recurrent esophageal spiration and thus could 
contribute to the lung injury [111]. 
The treatment and prognosis of bronchiolitis obliterans associated with 
bone marrow transplantation are unclear. Bronchodilators and corticosteroids, 
in the majority of cases, have not improved the airflow limitation. Furthermore, 
the use of immunosuppressive agents for the treatment of chronic GVHD has 
had no consistent beneficial effect on pulmonary function. Consequently, it 
would appear that early recognition and management of this process are re- 
quired if successful treatment is to be attained. The prognosis is quite variable. 
A significant number of the patients reported had progressive or persistent 
disease and many died as a result of respiratory failure. 
Heart-Lung Transplation. Heart-lung transplantation is being utilized increas- 
ingly for the management chronic lung and/or heart disease: end-stage pulmo- 
nary vascular disease, idiopathic cardiomyopathy, coronary artery disease, 
congenital heart disease, terminal pulmonary lymphangioleiomyomatosis, cys- 
tic fibrosis, and end-stage Eizenmenger's syndrome. Recently it has been noted 
that obliterative bronchiolitis is a major complication i  long-term survivors of 
heart-lung transplantation [1, 11, 12, 29, 45, 80, 119, 136]. The clinical presen- 
tation occurs several months to several years following transplantation. Cough 
productive of mucopurulent sputum followed by progressive dyspnea is com- 
mon. The chest examination revealed diffuse coarse crepitations and expir- 
atory rhonchi. 
Chest radiographs reveal diffuse peribronchial and interstitial infiltrates 
with variable pleural thickening and bronchography revealed cylindrical bron- 
chiectasis in those examined. Arterial hypoxemia nd hypocapnia re univer- 
sally present. Pulmonary function tests demonstrate irreversible airflow ob- 
struction, often with an associated reduction in total lung capacity. The 
diffusing capacity of carbon monoxide is moderately depressed. Spontaneous 
improvement does not occur often. 
On pathologic examination, patients have evidence of bronchiolitis obli- 
terans with patchy involvement throughout all areas of the lung [136]. Mucus 
inspissation and distal obstructive changes were frequently associated. Diffuse 
increases in peribronchial and interstitial fibrosis were present in all biopsy 
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specimens. Pleural, venous, and arteriosclerotic vascular changes were com- 
mon. These changes are different from those of the acute pulmonary rejection, 
which is characterized by perivascular lymphocytic uffing and diffuse alveolar 
damage. 
Yousem and co-investigators [136] have suggested the following as possible 
causes of bronchiolitis obliterans in patients who have undergone heart-lung 
transplantation: (I) recurrent or persistent bacterial or viral infections; (2) im- 
mune reaction to transplanted lung, for example, GVHD or transplant rejec- 
tion; (3) altered mucociliary clearance as a result of impaired ciliary function 
caused by injury to the pulmonary nerve supply or abnormal mucus chemistry 
and viscosity; (4) bronchial artery ligation leading to alteration in the repair 
process of injured bronchi and bronchioles; (5) reaction to immunosuppressive 
drugs, especially cyclosporine, which has been shown to have fibroproliferative 
properties that could cause progressive narrowing and obliteration of the af- 
fected bronchioles; and (5) loss of cough reflex and aspiration leading to the 
establishment of a milieu necessary to encourage the continued and persistent 
growth of infectious agents. 
No clearly useful treatment protocol has been found. Corticosteroids, 
bronchodilators, and antibiotics have been used without any documented stabi- 
lization or reversal of disease in the majority of patients. Recently, an immuno- 
suppressive regimen of cyclosporine, prednisone, and azathioprine has been 
suggested as effective in treating bronchiolitis obliterans. A prospective study 
utilizing this regimen is required to determine its efficacy [1,45]. Retransplanta- 
tion has been a successful alternative in patients with progressive disease. 
Miscellaneous Processes 
Idiopathic Pulmonary Fibrosis 
Hamman and Rich [54] mentioned small airway narrowing in their original 
cases of rapidly progressive idiopathic pulmonary fibrosis. Liebow and Car- 
rington [72] described this lesion superimposed on a background of usual inter- 
stitial pneumonia. Some cases of bronchiolitis obliterans d organizing pneu- 
monia have a rapidly progressive course resulting in death that is very similar 
to the Hamman-Rich syndrome. Since this lesion is frequently confused with 
IPF, one wonders if many of these cases of Hamman-Rich syndrome are not 
examples of BOOP. 
Hypersensitivity Pneumonitis 
Interstitial pneumonitis (100%) and granulomas (70%) are the most common 
pathologic abnormalities identified in patients with hypersensitivity pneumoni- 
tis. However, bronchiolar lesions (bronchiolitis obliterans) areseen in 50% or 
more of the patients [100, 110] (Fig. 4). A reversible restrictive process is the 
most common physiological bnormality in chronic hypersensitivity pneumoni- 
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Fig. 4. Hypersensitivity pneumonitis. Narrowing of airway lumen and marked inflammation 
(bronchiolitis). Multinucleate giant cells are seen in th  wall of the airway; a lymphoid aggregate is 
also present. The surrounding parenchyma is minimally involved. 
tis. Small airway dysfunction may be present in patients with early hypersensi- 
tivity pneumonitis. As the disease progresses, it may cause both an obstructive 
or restrictive process depending on the predominant histopathologic process 
present. 
Malignant Histocytosis 
Colby and co-workers [19] described the clinicopathologic spectrum of pulmo- 
nary involvement in malignant histiocytosis. The tumor is systemic and corn- 
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posed of malignant cells with morphologic and functional characteristics of 
histiocytes. The clinical presentation is variable. Fever, cough, lymphadeno- 
pathy, hepatosplenomegaly, and pancytopenia are common. The chest x-ray is 
frequently abnormal and reveals diffuse bilateral infiltrates (reticular, reticu- 
lonodular) or discrete nodules, with or without pleural effusions. Three of 5 
patients died within 10 months of presentation. The predominant histologic 
feature is a nondestructive nodular infiltrate within pulmonary lymphatics and a 
tendency to invade adjacent structures. Invasion and occlusion of small air- 
ways, as well as bronchiolitis obliterans were identified in 3 of the 5 cases 
reported. 
Chronic Eosinophilic Pneumonia 
Eosinophilic pneumonia is a nonspecific term that refers to several entities that 
have in common pulmonary infiltration with lung and/or blood eosinophilia. 
The syndrome of chronic eosinophilic pneumonia is characterized by fever, 
cough, dyspnea, weight loss, and malaise. The disease often waxes and wanes. 
Physical examination reveals wheezes in some patients. The chest x-ray "typi- 
cally" shows dense, progressive consolidation that frequently appears in the 
periphery of the lungs without a clear relationship to segmental nd lobar 
anatomy. The histopathologic features are primarily characterized by infiltra- 
tion of many mature eosinophils and a small number of lymphocytes and 
plasma cells. Multinucleated giant cells, Charcot-Leyden crystals, sarcoidlike 
granulomata, mild angiitis, edema, and proteinaceous exudates also occur. 
Bronchiolitis obliterans is a rare abnormality in the process [38, 86]. 
Diffuse Panbronchiolitis 
Homma and co-workers [58] recently described their experience with 82 histo- 
logically confirmed cases collected through a nationwide survey in Japan. The 
disease is most prevalent in men. The age of onset is variable. Chronic cough, 
exertional dyspnea, wheezing, and chronic parasinusitis are the common clini- 
cal manifestations of this disease. Pulmonary function tests reveal marked 
obstructive ventilatory defect and hypoxemia. The chest roentgenogram often 
reveals small nodular shadows (up to 2 mm in diameter) diffusely throughout 
both lung fields. Hyperinflation may also be present. On pathologic examina- 
tion the lesions are characterized by thickening of the walls of respiratory 
bronchioles with infiltration of lymphocytes, plasma cells, and histiocytes, and 
extension of the inflammatory changes toward peribronchiolar tissue. Ad- 
vanced disease is manifested by secondary ectasia of proximal bronchioli. The 
prognosis is often poor with rapid progress and a fatal outcome. 
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Fig. 5. Respiratory bronchiolitis. Low magnification reveals a bronchiole that is ectatic and has 
mucus stasis. The walls are thickened and there is extension of the bronchiolar metaplastic epithe- 
lium into the terminal bronchiole and alveolar duct. 
Respiratory Bronchiolitis 
Respiratory bronchiolitis is a distinct pathologic lesion commonly found in 
cigarette smokers [58]. It is characterized by the accumulation of pigmented 
alveolar macrophages within respiratory bronchioles and adjacent air spaces, 
often associated with mild thickening of the peribronchiolar interstitium (Fig. 
5). It is occasionally seen in nonsmokers and thus may be associated with other 
environmental or occupational insults. Recognized primarily in autopsy speci- 
mens from victims of sudden death or in lungs excised for unrelated solitary 
nodule, it has generally been considered of little clinical consequence. Re- 
cently, it has been recognized that respiratory bronchiolitis is an uncommon 
cause of chronic lung disease, primarily in heavy cigarette smokers [7, 92]. It is 
often confused with idiopathic pulmonary fibrosis because the patients present 
with cough, dyspnea, and have crackles on physical examination. Diffuse inter- 
stitial infiltrates are present on the chest radiograph and pulmonary function 
tests reveals mild to moderate restriction and reduced iffusing capacity. 
Respiratory bronchiolitis also occurs in patients with mineral dust expo- 
sure, such as asbestos. This is thought to be an early tissue reaction, with 
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scarring and inflammation in the membranous bronchioles; commonly these 
lesions contain a large amount of pigment [17, 18]. 
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